Please ensure Javascript is enabled for purposes of website accessibility

Why COVID-19 News Caused ResMed Shares to Tumble 10.3% Today

By Todd Campbell - Mar 19, 2020 at 5:28PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A push to increase the availability of ventilators by repurposing existing manufacturing capacity could reduce demand for ResMed.

What happened

After manufacturing companies disclosed that discussions are underway to repurpose idled manufacturing capacity to produce ventilators, ResMed Inc. (RMD -1.54%) shares lost 10.3% of their value on Thursday.

So what

ResMed is a healthcare company best known for manufacturing continuous positive airway pressure (CPAP) machines used to treat sleep apneas. However, it also produces non-invasive ventilators used to boost oxygen intake by patients with certain diseases and conditions, such as chronic obstructive pulmonary disease (COPD).

A ventilator in an operating room.


Demand for ventilators to provide oxygen therapy is increasing because COVID-19 can cause life-threatening respiratory illness. So far, 236,420 COVID-19 cases have been diagnosed worldwide, including 11,274 cases in the United States. According to the Centers for Disease Control and Prevention (CDC), over 20% of the 2,449 cases identified in the U.S. between February 12 through March 16, 2020 required hospitalization.

Oxygen therapy is a primary intervention for severely ill patients, so worries that ventilator demand could outstrip existing supply is growing. In response, companies including Ford (F -3.38%) and General Motors (GM -5.05%) have announced they're evaluating their ability to shift manufacturing capacity to the production of ventilators. On Wednesday, both automakers reported they're halting auto production at their North American plants to protect workers.

Now what

If capacity doesn't increase, then healthcare providers could be forced to ration the use of existing ventilators, potentially jeopardizing lives. Although more competition poses a headwind to sales, orders for ResMed's non-invasive ventilators should still increase, and its CPAP business shouldn't be affected. If that's the case, then this could be an opportunity to buy shares.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

ResMed Inc. Stock Quote
ResMed Inc.
$209.63 (-1.54%) $-3.28
Ford Motor Company Stock Quote
Ford Motor Company
$11.13 (-3.38%) $0.39
General Motors Company Stock Quote
General Motors Company
$31.76 (-5.05%) $-1.69

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.